Protein corona of airborne nanoscale PM2.5 induces aberrant proliferation of human lung fibroblasts based on a 3D organotypic culture.

Homo sapiens ascorbic acidultrafine respirable suspended particulate matter

Study subjects

soma:li2018-3dhlf-001

Primary human lung fibroblasts in a 3D fibrin-hydrogel organotypic culture

type: CellularSystem Homo sapiens NCBITaxon:9606 fibroblast of lung CL:0002553

Oxidative stress assays

OX:li2018-3dhlf-ros-dose

ROS fluorescence in 3D-cultured HLFs across an NPM-protein corona dose series

Intracellular ROS labelled with DCFH-DA in 3D-cultured HLFs exposed for three days to the NPM-protein corona at 5, 10 and 20 ug/ml NPM. ROS increased positively with NPM concentration. Fluorescence intensity is reported only in Fig. 5A with images in Fig. 5F-H, so no numeric value is recorded. Significance versus control was marked *P < 0.05, **P < 0.01 in the figure legend without per-group attribution in the text.

ros probe type: DCFH-DA

Exposure conditions

ConditionAgentConcentrationDuration
Control, HLF medium alone in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-control
— — 3 day
NPM-protein corona at 5 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc5
ultrafine respirable suspended particulate matter
ENVO:01000416
5 microgram per milliliter 3 day
NPM-protein corona at 10 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc10
ultrafine respirable suspended particulate matter
ENVO:01000416
10 microgram per milliliter 3 day
NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc20
ultrafine respirable suspended particulate matter
ENVO:01000416
20 microgram per milliliter 3 day

Outputs

GroupOutputDescription
control Control 3D-HLFs - ROS fluorescence
OX:li2018-3dhlf-ros-dose-output-control · under EXPOSURE:li2018-3dhlf-control
Reference condition, HLF medium alone. Figure-only values; none recorded.
treated NPC 5 ug/ml NPM 3D-HLFs - ROS fluorescence
OX:li2018-3dhlf-ros-dose-output-npc5 · under EXPOSURE:li2018-3dhlf-npc5
Lowest dose of the dose series; ROS increased relative to control. Figure-only values; none recorded.
treated NPC 10 ug/ml NPM 3D-HLFs - ROS fluorescence
OX:li2018-3dhlf-ros-dose-output-npc10 · under EXPOSURE:li2018-3dhlf-npc10
Middle dose of the dose series. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM 3D-HLFs - ROS fluorescence
OX:li2018-3dhlf-ros-dose-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20
Highest dose of the dose series; largest ROS increase. Figure-only values; none recorded.

Evidence

shows a positive ROS increase in relation to the NPM concentration.
SUPPORT IN VITRO PMID:29386584

States exactly what this assay records: ROS fluorescence in the 3D-cultured HLFs rose with the NPM concentration of the protein corona.

Taken together, these results demonstrate that the NPM-protein corona is expected to result in a limited increase in ROS levels.
SUPPORT IN VITRO PMID:29386584

The authors' summary of the magnitude of the ROS response recorded here - an increase, but a limited one.

OX:li2018-3dhlf-ros-modulators

ROS fluorescence in 3D-cultured HLFs with vitamin C or TGF-beta1

ROS labelled with DCFH-DA in 3D-cultured HLFs exposed for three days to the NPM-protein corona (20 ug/ml NPM), to the same corona co-treated with vitamin C 0.1 mg/ml, or to TGF-beta1 2 ng/ml. Vitamin C repressed ROS generation and TGF-beta1 promoted it, reproducing the corona response. Values reported only in Fig. 5B with images in Fig. 5C-E; none recorded.

ros probe type: DCFH-DA

Exposure conditions

ConditionAgentConcentrationDuration
Control, HLF medium alone in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-control
— — 3 day
NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc20
ultrafine respirable suspended particulate matter
ENVO:01000416
20 microgram per milliliter 3 day
NPM-protein corona at 20 ug/ml NPM with vitamin C 0.1 mg/ml, three days
EXPOSURE:li2018-3dhlf-npc20-vc
ascorbic acid
CHEBI:22652
0.1 milligram per milliliter 3 day
TGF-beta1 2 ng/ml in the 3D fibrin construct, three days (positive comparator)
EXPOSURE:li2018-3dhlf-tgfb1
— 2 nanogram per milliliter 3 day

Outputs

GroupOutputDescription
control Control 3D-HLFs - ROS fluorescence
OX:li2018-3dhlf-ros-modulators-output-control · under EXPOSURE:li2018-3dhlf-control
Reference condition, HLF medium alone. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM 3D-HLFs - ROS fluorescence
OX:li2018-3dhlf-ros-modulators-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20
Corona group against which the modulators were compared; ROS increased. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM plus vitamin C 3D-HLFs - ROS fluorescence
OX:li2018-3dhlf-ros-modulators-output-npc20-vc · under EXPOSURE:li2018-3dhlf-npc20-vc
ROS generation effectively repressed relative to the corona group. Figure-only values; none recorded.
treated TGF-beta1 2 ng/ml 3D-HLFs - ROS fluorescence
OX:li2018-3dhlf-ros-modulators-output-tgfb1 · under EXPOSURE:li2018-3dhlf-tgfb1
Positive comparator; TGF-beta1 promoted ROS. Figure-only values; none recorded.

Evidence

An antioxidant (vitamin C) effectively repressed ROS generation
SUPPORT IN VITRO PMID:29386584

States the vitamin C result this assay records: co-treatment suppressed the corona-driven ROS increase, which is the antioxidant control on the oxidative stress event.

TGF-β1 promoted ROS, as has been reported in the literature
SUPPORT IN VITRO PMID:29386584

States the positive-comparator result this assay records: TGF-beta1 raised ROS in the same 3D system.

OX:li2018-3dhlf-gsh

GSH fluorescence in 3D-cultured HLFs across the NPM-protein corona dose series and with vitamin C or TGF-beta1

Intracellular glutathione labelled with ThioGlo-1 in 3D-cultured HLFs after three days. GSH depletion was detected in every NPM-protein corona group (5, 10 and 20 ug/ml NPM) and in the TGF-beta1 group, accompanying the ROS rise; vitamin C co-treatment suppressed the depletion. Values reported only in Fig. 6A-B with images in Fig. 6C-H; none recorded.

Exposure conditions

ConditionAgentConcentrationDuration
Control, HLF medium alone in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-control
— — 3 day
NPM-protein corona at 5 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc5
ultrafine respirable suspended particulate matter
ENVO:01000416
5 microgram per milliliter 3 day
NPM-protein corona at 10 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc10
ultrafine respirable suspended particulate matter
ENVO:01000416
10 microgram per milliliter 3 day
NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc20
ultrafine respirable suspended particulate matter
ENVO:01000416
20 microgram per milliliter 3 day
NPM-protein corona at 20 ug/ml NPM with vitamin C 0.1 mg/ml, three days
EXPOSURE:li2018-3dhlf-npc20-vc
ascorbic acid
CHEBI:22652
0.1 milligram per milliliter 3 day
TGF-beta1 2 ng/ml in the 3D fibrin construct, three days (positive comparator)
EXPOSURE:li2018-3dhlf-tgfb1
— 2 nanogram per milliliter 3 day

Outputs

GroupOutputDescription
control Control 3D-HLFs - GSH fluorescence
OX:li2018-3dhlf-gsh-output-control · under EXPOSURE:li2018-3dhlf-control
Reference condition, HLF medium alone. Figure-only values; none recorded.
treated NPC 5 ug/ml NPM 3D-HLFs - GSH fluorescence
OX:li2018-3dhlf-gsh-output-npc5 · under EXPOSURE:li2018-3dhlf-npc5
GSH depletion detected. Figure-only values; none recorded.
treated NPC 10 ug/ml NPM 3D-HLFs - GSH fluorescence
OX:li2018-3dhlf-gsh-output-npc10 · under EXPOSURE:li2018-3dhlf-npc10
GSH depletion detected. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM 3D-HLFs - GSH fluorescence
OX:li2018-3dhlf-gsh-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20
GSH depletion detected. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM plus vitamin C 3D-HLFs - GSH fluorescence
OX:li2018-3dhlf-gsh-output-npc20-vc · under EXPOSURE:li2018-3dhlf-npc20-vc
GSH depletion effectively suppressed relative to the corona group. Figure-only values; none recorded.
treated TGF-beta1 2 ng/ml 3D-HLFs - GSH fluorescence
OX:li2018-3dhlf-gsh-output-tgfb1 · under EXPOSURE:li2018-3dhlf-tgfb1
Positive comparator; GSH depletion detected. Figure-only values; none recorded.

Evidence

GSH depletion was detected in all groups of NPM-protein corona preparations and TGF-β1
SUPPORT IN VITRO PMID:29386584

States exactly what this assay records: glutathione was depleted in every corona dose group and in the TGF-beta1 comparator.

Vitamin C effectively suppressed GSH depletion
SUPPORT IN VITRO PMID:29386584

States the antioxidant control result this assay records: vitamin C prevented the corona-driven GSH depletion.

OX:li2018-3dhlf-mda

Intracellular MDA in 3D-cultured HLFs across the NPM-protein corona dose series and with vitamin C or TGF-beta1

Malondialdehyde, a lipid peroxidation end product, measured by ELISA after three days. Despite the ROS rise and GSH depletion, the NPM-protein corona induced no MDA increase at any dose, and neither vitamin C nor TGF-beta1 changed MDA. This negative result is the basis for the authors' conclusion that the corona produces a limited ROS increase without oxidative damage. Values reported only in Fig. 7A-B; none recorded.

Exposure conditions

ConditionAgentConcentrationDuration
Control, HLF medium alone in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-control
— — 3 day
NPM-protein corona at 5 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc5
ultrafine respirable suspended particulate matter
ENVO:01000416
5 microgram per milliliter 3 day
NPM-protein corona at 10 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc10
ultrafine respirable suspended particulate matter
ENVO:01000416
10 microgram per milliliter 3 day
NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc20
ultrafine respirable suspended particulate matter
ENVO:01000416
20 microgram per milliliter 3 day
NPM-protein corona at 20 ug/ml NPM with vitamin C 0.1 mg/ml, three days
EXPOSURE:li2018-3dhlf-npc20-vc
ascorbic acid
CHEBI:22652
0.1 milligram per milliliter 3 day
TGF-beta1 2 ng/ml in the 3D fibrin construct, three days (positive comparator)
EXPOSURE:li2018-3dhlf-tgfb1
— 2 nanogram per milliliter 3 day

Outputs

GroupOutputDescription
control Control 3D-HLFs - intracellular MDA
OX:li2018-3dhlf-mda-output-control · under EXPOSURE:li2018-3dhlf-control
Reference condition. Figure-only values; none recorded.
treated NPC 5 ug/ml NPM 3D-HLFs - intracellular MDA
OX:li2018-3dhlf-mda-output-npc5 · under EXPOSURE:li2018-3dhlf-npc5
No MDA increase versus control. Figure-only values; none recorded.
treated NPC 10 ug/ml NPM 3D-HLFs - intracellular MDA
OX:li2018-3dhlf-mda-output-npc10 · under EXPOSURE:li2018-3dhlf-npc10
No MDA increase versus control. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM 3D-HLFs - intracellular MDA
OX:li2018-3dhlf-mda-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20
No MDA increase versus control even at the highest dose. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM plus vitamin C 3D-HLFs - intracellular MDA
OX:li2018-3dhlf-mda-output-npc20-vc · under EXPOSURE:li2018-3dhlf-npc20-vc
No change in MDA. Figure-only values; none recorded.
treated TGF-beta1 2 ng/ml 3D-HLFs - intracellular MDA
OX:li2018-3dhlf-mda-output-tgfb1 · under EXPOSURE:li2018-3dhlf-tgfb1
No change in MDA. Figure-only values; none recorded.

Evidence

The NPM-protein corona stimulated ROS generation but induced no MDA increase
REFUTE IN VITRO PMID:29386584

Recorded as REFUTE because this measurement argues against membrane lipid-peroxidation damage as part of the oxidative stress event: MDA did not rise even though ROS did.

Moreover, the antioxidant (vitamin C) and TGF-β1 showed no change in MDA or 8-OH-dG
REFUTE IN VITRO PMID:29386584

The modulator arms of this assay were also flat, so no treatment in the study produced a detectable lipid peroxidation signal.

However, ROS generation induced no oxidative damage.
REFUTE IN VITRO PMID:29386584

The authors' own reading of this and the 8-OH-dG assay: the ROS increase did not translate into oxidative damage.

OX:li2018-3dhlf-8ohdg

Intracellular 8-OH-dG in 3D-cultured HLFs across the NPM-protein corona dose series and with vitamin C or TGF-beta1

8-hydroxydeoxyguanosine, the most commonly measured marker of oxidative DNA damage, measured by ELISA after three days. The NPM-protein corona induced no variation in 8-OH-dG at any dose, and neither vitamin C nor TGF-beta1 changed it. Values reported only in Fig. 7C-D; none recorded.

Exposure conditions

ConditionAgentConcentrationDuration
Control, HLF medium alone in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-control
— — 3 day
NPM-protein corona at 5 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc5
ultrafine respirable suspended particulate matter
ENVO:01000416
5 microgram per milliliter 3 day
NPM-protein corona at 10 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc10
ultrafine respirable suspended particulate matter
ENVO:01000416
10 microgram per milliliter 3 day
NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc20
ultrafine respirable suspended particulate matter
ENVO:01000416
20 microgram per milliliter 3 day
NPM-protein corona at 20 ug/ml NPM with vitamin C 0.1 mg/ml, three days
EXPOSURE:li2018-3dhlf-npc20-vc
ascorbic acid
CHEBI:22652
0.1 milligram per milliliter 3 day
TGF-beta1 2 ng/ml in the 3D fibrin construct, three days (positive comparator)
EXPOSURE:li2018-3dhlf-tgfb1
— 2 nanogram per milliliter 3 day

Outputs

GroupOutputDescription
control Control 3D-HLFs - intracellular 8-OH-dG
OX:li2018-3dhlf-8ohdg-output-control · under EXPOSURE:li2018-3dhlf-control
Reference condition. Figure-only values; none recorded.
treated NPC 5 ug/ml NPM 3D-HLFs - intracellular 8-OH-dG
OX:li2018-3dhlf-8ohdg-output-npc5 · under EXPOSURE:li2018-3dhlf-npc5
No variation versus control. Figure-only values; none recorded.
treated NPC 10 ug/ml NPM 3D-HLFs - intracellular 8-OH-dG
OX:li2018-3dhlf-8ohdg-output-npc10 · under EXPOSURE:li2018-3dhlf-npc10
No variation versus control. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM 3D-HLFs - intracellular 8-OH-dG
OX:li2018-3dhlf-8ohdg-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20
No variation versus control even at the highest dose. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM plus vitamin C 3D-HLFs - intracellular 8-OH-dG
OX:li2018-3dhlf-8ohdg-output-npc20-vc · under EXPOSURE:li2018-3dhlf-npc20-vc
No change in 8-OH-dG. Figure-only values; none recorded.
treated TGF-beta1 2 ng/ml 3D-HLFs - intracellular 8-OH-dG
OX:li2018-3dhlf-8ohdg-output-tgfb1 · under EXPOSURE:li2018-3dhlf-tgfb1
No change in 8-OH-dG. Figure-only values; none recorded.

Evidence

The NPM-protein corona also induced no variation in 8-OH-dG levels in the 3D-cultured HLFs
REFUTE IN VITRO PMID:29386584

Recorded as REFUTE because this measurement argues against oxidative DNA damage as part of the oxidative stress event: 8-OH-dG was unchanged while ROS rose.

Moreover, the antioxidant (vitamin C) and TGF-β1 showed no change in MDA or 8-OH-dG
REFUTE IN VITRO PMID:29386584

The modulator arms of this assay were flat as well, so no treatment produced a detectable oxidative DNA damage signal.

Gene expression assays

GE:li2018-3dhlf-asma-dose

Alpha-SMA expression in 3D-cultured HLFs across an NPM-protein corona dose series

Alpha-smooth muscle actin immunofluorescence in 3D-cultured HLFs after three days of exposure to the NPM-protein corona at 5, 10 and 20 ug/ml NPM. The corona stimulated HLFs to express alpha-SMA and expression was positively correlated with the NPM exposure concentration. Alpha-SMA is a key protein of activated, not quiescent, fibroblasts and a fibrosis marker, so this is the proliferation pathway the authors propose. Fluorescence intensity reported only in Fig. 8A with images in Fig. 8F-H; no numeric value recorded.

target gene: NCBIGene:59 gene expression method: immunofluorescence confocal imaging with ImageJ intensity quantification normalization reference: untreated control group fluorescence intensity

Exposure conditions

ConditionAgentConcentrationDuration
Control, HLF medium alone in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-control
— — 3 day
NPM-protein corona at 5 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc5
ultrafine respirable suspended particulate matter
ENVO:01000416
5 microgram per milliliter 3 day
NPM-protein corona at 10 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc10
ultrafine respirable suspended particulate matter
ENVO:01000416
10 microgram per milliliter 3 day
NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc20
ultrafine respirable suspended particulate matter
ENVO:01000416
20 microgram per milliliter 3 day

Outputs

GroupOutputDescription
control Control 3D-HLFs - alpha-SMA fluorescence
GE:li2018-3dhlf-asma-dose-output-control · under EXPOSURE:li2018-3dhlf-control
Reference condition, HLF medium alone. Figure-only values; none recorded.
treated NPC 5 ug/ml NPM 3D-HLFs - alpha-SMA fluorescence
GE:li2018-3dhlf-asma-dose-output-npc5 · under EXPOSURE:li2018-3dhlf-npc5
Lowest dose; alpha-SMA raised versus control. Figure-only values; none recorded.
treated NPC 10 ug/ml NPM 3D-HLFs - alpha-SMA fluorescence
GE:li2018-3dhlf-asma-dose-output-npc10 · under EXPOSURE:li2018-3dhlf-npc10
Middle dose of the positively correlated series. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM 3D-HLFs - alpha-SMA fluorescence
GE:li2018-3dhlf-asma-dose-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20
Highest dose; greatest alpha-SMA expression. Figure-only values; none recorded.

Evidence

The results demonstrated that the NPM-protein corona stimulated HLFs to express α-SMA.
SUPPORT IN VITRO PMID:29386584

States the core result this assay records: the NPM-protein corona induced alpha-SMA expression in the 3D-cultured HLFs.

α-SMA expression was positively correlated with the NPM exposure concentration
SUPPORT IN VITRO PMID:29386584

States the dose-response this assay's three corona groups record.

α-SMA is a key protein expressed by activated HLFs but not by quiescent fibroblasts.
SUPPORT IN VITRO PMID:29386584

Establishes why alpha-SMA induction is read as fibroblast activation and therefore informs the proliferation key event.

GE:li2018-3dhlf-asma-modulators

Alpha-SMA expression in 3D-cultured HLFs with vitamin C or TGF-beta1

Alpha-SMA immunofluorescence in 3D-cultured HLFs after three days of exposure to the NPM-protein corona (20 ug/ml NPM), the same corona co-treated with vitamin C 0.1 mg/ml, or TGF-beta1 2 ng/ml. Vitamin C repressed alpha-SMA secretion, tying the induction to the ROS it also suppressed; TGF-beta1 promoted alpha-SMA, reproducing the corona effect. Values reported only in Fig. 8B with images in Fig. 8C-E; none recorded.

target gene: NCBIGene:59 gene expression method: immunofluorescence confocal imaging with ImageJ intensity quantification normalization reference: untreated control group fluorescence intensity

Exposure conditions

ConditionAgentConcentrationDuration
Control, HLF medium alone in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-control
— — 3 day
NPM-protein corona at 20 ug/ml NPM in the 3D fibrin construct, three days
EXPOSURE:li2018-3dhlf-npc20
ultrafine respirable suspended particulate matter
ENVO:01000416
20 microgram per milliliter 3 day
NPM-protein corona at 20 ug/ml NPM with vitamin C 0.1 mg/ml, three days
EXPOSURE:li2018-3dhlf-npc20-vc
ascorbic acid
CHEBI:22652
0.1 milligram per milliliter 3 day
TGF-beta1 2 ng/ml in the 3D fibrin construct, three days (positive comparator)
EXPOSURE:li2018-3dhlf-tgfb1
— 2 nanogram per milliliter 3 day

Outputs

GroupOutputDescription
control Control 3D-HLFs - alpha-SMA fluorescence
GE:li2018-3dhlf-asma-modulators-output-control · under EXPOSURE:li2018-3dhlf-control
Reference condition. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM 3D-HLFs - alpha-SMA fluorescence
GE:li2018-3dhlf-asma-modulators-output-npc20 · under EXPOSURE:li2018-3dhlf-npc20
Corona group against which the modulators were compared. Figure-only values; none recorded.
treated NPC 20 ug/ml NPM plus vitamin C 3D-HLFs - alpha-SMA fluorescence
GE:li2018-3dhlf-asma-modulators-output-npc20-vc · under EXPOSURE:li2018-3dhlf-npc20-vc
Alpha-SMA secretion effectively repressed relative to the corona group. Figure-only values; none recorded.
treated TGF-beta1 2 ng/ml 3D-HLFs - alpha-SMA fluorescence
GE:li2018-3dhlf-asma-modulators-output-tgfb1 · under EXPOSURE:li2018-3dhlf-tgfb1
Positive comparator; TGF-beta1 promoted alpha-SMA expression. Figure-only values; none recorded.

Evidence

Vitamin C effectively repressed the secretion of α-SMA
SUPPORT IN VITRO PMID:29386584

States the antioxidant-arm result this assay records, which is the authors' evidence that alpha-SMA induction is ROS-dependent.

TGF-β1 promoted α-SMA expression
SUPPORT IN VITRO PMID:29386584

States the positive-comparator result this assay records: TGF-beta1 raised alpha-SMA in the same 3D system.

Key events

KE:mie-oxidative-stress

Increased oxidative stress

level: molecular action: increased view in pooled network
Taken together, these results demonstrate that the NPM-protein corona is expected to result in a limited increase in ROS levels.
SUPPORT IN VITRO PMID:29386584

The paper's own characterisation of the oxidative stress event it induced: a real but limited rise in ROS, accompanied by GSH depletion and no damage markers.

KE:ke-increased-proliferation

Increased cell proliferation

level: cellular action: increased view in pooled network
The protein corona is believed to mitigate NPM cytotoxicity and further stimulate aberrant HLF proliferation.
SUPPORT IN VITRO PMID:29386584

The paper's conclusion naming the proliferation event, and noting that the protein coat is what makes it possible by blunting the cytotoxicity of naked NPM.

The results demonstrated that the NPM-protein corona potentially promoted the cell growth of 3D-cultured HLFs.
SUPPORT IN VITRO PMID:29386584

The MTT result establishing that proliferation increased in the exposed 3D cultures.

Key-event relationships

KER:li2018-oxidative-stress-to-proliferation

Increased oxidative stress leads to increased cell proliferation in 3D-cultured human lung fibroblasts

Dose-response by MTT after three days of exposure in the 3D fibrin construct: cell viabilities of 103%, 109% and 113% of control at NPM-protein corona concentrations of 5, 10 and 20 ug/ml NPM, with the 20 ug/ml group significant versus control at p < 0.01. The specificity controls were flat: naked NPM at 20 ug/ml gave 104% and pure serum 105%, so neither component alone reproduced the effect. Vitamin C co-treatment lowered viability relative to the 20 ug/ml corona group, and TGF-beta1 2 ng/ml reproduced the whole response. No numeric values are available for the intervening ROS or alpha-SMA steps, which are reported as fluorescence bar charts only, so the quantitative chain stops at the proliferation endpoint.

ROS, as signalling molecules, play an important role in mediating α-SMA upregulation.
SUPPORT IN VITRO PMID:29386584

The mechanistic step joining the two key events: the ROS increase acts as a signal that upregulates alpha-SMA.

ROS are signal molecules that stimulate cell proliferation without inducing oxidative damage.
SUPPORT IN VITRO PMID:29386584

States the relationship directly, and why it is a signalling edge rather than a damage edge - the damage markers MDA and 8-OH-dG did not move.

the addition of an antioxidant was shown to diminish the proliferation efficiency of NPM-protein corona stimulation
SUPPORT IN VITRO PMID:29386584

The interventional evidence for this edge: blocking the upstream oxidative stress with vitamin C reduced the downstream proliferation.

This suggests that oxidative stress is associated with HLF proliferation.
SUPPORT IN VITRO PMID:29386584

The authors' own statement of the relationship drawn from the antioxidant experiment.

ROS-activated alpha-smooth muscle actin (α-SMA) is considered to be one of the proliferation pathways.
SUPPORT IN VITRO PMID:29386584

The abstract's framing of the pathway, naming ROS-activated alpha-SMA as the route to proliferation.

Nanoscale airborne particles could form a protein corona in the body and initiate HLF proliferation by ROS-mediated α-SMA upregulation, which may further result in pulmonary fibrosis.
SUPPORT IN VITRO PMID:29386584

The full proposed chain, including the hedged extension to pulmonary fibrosis that this extraction deliberately does not record as a key event.

Cell numbers increased in a dose-dependent manner
SUPPORT IN VITRO PMID:29386584

The dose-dependence of the downstream event, which parallels the dose-dependence of the upstream ROS rise and of alpha-SMA.

The cell viabilities were 103%, 109% and 113%, respectively.
SUPPORT IN VITRO PMID:29386584

The numeric dose-response recorded in this relationship's description, for the corona at 5, 10 and 20 ug/ml NPM.

significantly promoted an increase in HLFs
SUPPORT IN VITRO PMID:29386584

The significance of the highest corona dose versus control for the downstream proliferation event.

The cell viabilities were 105% and 104%, respectively
SUPPORT IN VITRO PMID:29386584

The specificity controls - pure serum and naked NPM - neither of which reproduced the proliferation, so the corona complex is what drives the edge.

Cell viability declined compared to that with the NPM-protein corona
SUPPORT IN VITRO PMID:29386584

The vitamin C arm of the MTT assay, the quantitative counterpart of the antioxidant evidence for this edge.

TGF-β1 was also shown to promote HLF proliferation in the 3D model
SUPPORT IN VITRO PMID:29386584

The positive comparator closing the loop: TGF-beta1 raised ROS, depleted GSH, raised alpha-SMA and raised proliferation, matching the corona response at every step of this edge.

Based on a 3D organotypic cell culture, the protein corona was shown to mitigate NPM cytotoxicity and further stimulate the proliferation of human lung fibroblasts (HLFs).
SUPPORT IN VITRO PMID:29386584

The abstract's statement of the model system and the overall outcome this relationship describes.

Consequently, the final cell exposure concentrations of NPM were 5, 10 and 20 μg/ml.
SUPPORT IN VITRO PMID:29386584

The Methods statement fixing the three corona doses used throughout; the earlier 25/50/100 ug/ml figures are pre-dilution stock concentrations, not exposures.

The cell exposure concentrations of TGF-β1 and vitamin C in the 3D systems were 2 ng/ml and 0.1 mg/ml, respectively.
SUPPORT IN VITRO PMID:29386584

The Methods statement fixing the comparator and antioxidant doses recorded on the exposure conditions above.

Following exposure to the different test groups, HLFs were cultured in the 3D culture systems for three days.
SUPPORT IN VITRO PMID:29386584

The Methods statement fixing the three-day exposure duration recorded on every exposure condition above.

Cells were suspended at 2 × 106 cells/ml and mixed with the NPC solutions.
SUPPORT IN VITRO PMID:29386584

The seeding density of the 3D construct, recorded in the culture protocol.

Cell proliferation was measured using an MTT kit (Nanjing Jiancheng, China).
SUPPORT IN VITRO PMID:29386584

The method behind the viability percentages in this relationship's description, recorded in the MTT protocol.

To verify the biological function of the protein corona, pure serum and NPM
SUPPORT IN VITRO PMID:29386584

Names the two specificity-control arms whose viabilities are quoted above, confirming they were run to test the corona's own contribution.

Protocols

PROTOCOL:li2018-3dculture-001

3D organotypic fibrin-hydrogel culture of human lung fibroblasts

type: Protocol

Human lung fibroblasts were suspended at 2 x 10^6 cells/ml, mixed with the exposure solution, fibrinogen (10 mg/ml) and thrombin (100 U/ml) in a ratio of 60:20:19:1 on ice, and seeded as 15 ul aliquots in a microfluidic chip (AIM Biotech, Singapore) for imaging or 50 ul aliquots in a 96-well plate for quantitative assays. Gelation ran 1 h at 37 C, after which the construct was filled with HLF culture medium, replaced daily, and cultured for three days. Fibrinogen was dissolved in FBS-free HLF medium; thrombin in DPBS containing 0.1% BSA.

quality control criteria: Live/dead and nuclear fluorescence confirmed intact, viable cells with clear nuclei in the fibrin scaffold before exposure readouts

Equipment: Microfluidic chip (AIM Biotech, Singapore); Fibrinogen (Sigma) and thrombin (Sigma); Confocal microscope (Olympus IX81)

PROTOCOL:li2018-mtt-001

MTT assay for cell proliferation of 3D-cultured HLFs

type: MolecularAssayProtocol

After three days of exposure the cell medium was removed by pipetting and 100 ul of gel dissociation saline solution (Biovision) was added. Mixtures were incubated at room temperature for 5-10 min and pipetted with a 1 ml tip until the fibrin matrix dissolved, then centrifuged at 1,000 x g for 5 min at 4 C and the supernatant removed. Cell proliferation was measured with an MTT kit (Nanjing Jiancheng, China) and reported as cell viability relative to the untreated control.

detection method: MTT colorimetric assay kit (Nanjing Jiancheng) normalization method: percentage of the untreated control group

Equipment: Microplate reader; MTT assay kit (Nanjing Jiancheng); Gel dissociation saline solution (Biovision)

PROTOCOL:li2018-dcfhda-001

DCFH-DA fluorescence detection of intracellular ROS in 3D-cultured HLFs

type: ImagingProtocol

Intracellular reactive oxygen species were labelled with DCFH-DA (Merck KGaA, Germany). Images of fluorochrome-labelled ROS in 3D-cultured HLFs were captured on a confocal microscope (Olympus IX81) at x10 magnification and processed with Imaris software. For quantification, 3D-cultured HLFs on cell plates were released from the fibrin matrix with gel dissociation saline solution and ROS fluorescence intensity was read on a fluorescence reader (FLx800; BioTek Instruments).

fluorescent labeling: DCFH-DA (Merck KGaA) fluorescent tracer: DCFH-DA

Equipment: Confocal microscope (Olympus IX81); Fluorescence reader (FLx800, BioTek Instruments); DCFH-DA probe (Merck KGaA)

PROTOCOL:li2018-thioglo-001

ThioGlo-1 fluorescence detection of intracellular GSH in 3D-cultured HLFs

type: ImagingProtocol

Intracellular glutathione was labelled with ThioGlo(TM)-1 (Merck KGaA, Germany). Images of fluorochrome-labelled GSH in 3D-cultured HLFs were captured on a confocal microscope (Olympus IX81) at x10 magnification. GSH fluorescence intensity was quantified on a fluorescence reader (FLx800; BioTek Instruments) after the cells were released from the fibrin matrix.

fluorescent labeling: ThioGlo(TM)-1 (Merck KGaA) fluorescent tracer: ThioGlo-1

Equipment: Confocal microscope (Olympus IX81); Fluorescence reader (FLx800, BioTek Instruments); ThioGlo-1 probe (Merck KGaA)

PROTOCOL:li2018-elisa-001

ELISA quantification of MDA and 8-OHdG in 3D-cultured HLFs

type: MolecularAssayProtocol

Concentrations of malondialdehyde (MDA, a lipid peroxidation end product) and 8-hydroxydeoxyguanosine (8-OHdG, a marker of oxidative DNA damage) were measured with ELISA kits according to the manufacturer's instructions (Nanjing Jiancheng, China), on 3D-cultured HLFs recovered from the fibrin matrix by gel dissociation and centrifugation.

detection method: ELISA kits (Nanjing Jiancheng)

Equipment: Microplate reader; MDA and 8-OHdG ELISA kits (Nanjing Jiancheng)

PROTOCOL:li2018-asma-if-001

Alpha-SMA immunofluorescence in 3D-cultured HLFs

type: StainingProtocol

Alpha-smooth muscle actin was detected with a fluorescent anti-alpha-SMA agent (Abcam, USA) in HLFs cultured in the microfluidic chip. Nuclei were counterstained with DAPI (Invitrogen) and live cells labelled with an Invitrogen live-cell dye. 3D fluorescence images were captured on a confocal microscope (Olympus IX81) at x10 magnification and processed with Imaris software; the fluorescence intensity of alpha-SMA expression was analysed with ImageJ software.

staining type: immunofluorescence detection method: confocal fluorescence microscopy with ImageJ intensity quantification counterstain: DAPI (Invitrogen)

Equipment: Confocal microscope (Olympus IX81); Imaris software (Bitplane Scientific Software); ImageJ software